Skip to content

NIH Websites Are Changing

Beginning in late July, NIH will start introducing a new website experience designed to make it easier to find health information, research, funding opportunities, and other resources. During the transition, you may notice changes to navigation, page layouts, and where some information is located. Learn more in our Frequently Asked Questions.

Potential Way to Halt Blinding Macular Degeneration Identified

January 22, 2020
Age-Related Macular Degeneration Genetics Regenerative Medicine Retina
Basic Research
Grantee
Brad Gelfand, Ph.D., in the laboratory

Researcher Brad Gelfand has discovered an unexpected connection between the two main forms of age-related macular degeneration (AMD). Credit: Dan Addison, University of Virginia Communications.

Researchers at the University of Virginia have successfully treated age-related macular degeneration (AMD) in mice after finding an unexpected link between the two main forms of the blinding eye disease, the leading cause of vision loss in people 60 and older. They found that the absence of a particular enzyme could drive both forms of AMD. The enzyme, called Dicer, is lost with age, and that loss leads to an overgrowth of blood vessels in the retina and other damage.

Read more at University of Virginia News
Back to top